<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://ep.bmj.com">
<title>Archives of Disease in Childhood - Education and Practice current issue</title>
<link>http://ep.bmj.com</link>
<description>Archives of Disease in Childhood - Education and Practice RSS feed -- current issue</description>
<prism:eIssn>1743-0593</prism:eIssn>
<prism:coverDisplayDate>Jun  1 2026 12:00:00:000AM</prism:coverDisplayDate>
<prism:publicationName>Archives of Disease in Childhood - Education and Practice</prism:publicationName>
<prism:issn>1743-0585</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/111/3/85?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/111/3/86?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/111/3/92?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/111/3/97?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/111/3/103?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/111/3/107?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/111/3/111?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/111/3/119?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/111/3/123?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/111/3/126?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/111/3/128?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://hwmaint.ep.bmj.com/misc/home/ADC_95x60.gif" />
</channel>
<image rdf:about="http://hwmaint.ep.bmj.com/misc/home/ADC_95x60.gif">
<title>Archives of Disease in Childhood - Education and Practice</title>
<url>http://hwmaint.ep.bmj.com/misc/home/ADC_95x60.gif</url>
<link>http://ep.bmj.com</link>
</image>
<item rdf:about="http://ep.bmj.com/cgi/content/short/111/3/85?rss=1">
<title><![CDATA[Epistle]]></title>
<link>http://ep.bmj.com/cgi/content/short/111/3/85?rss=1</link>
<description><![CDATA[ <p>As summer begins, I hope you are feeling refreshed and ready to explore another issue of <I>Education &amp; Practice,</I> which brings together engaging, clinically relevant articles for paediatric practitioners. The Fifteen-Minute Consultation by Alexandra Blaschitz and Wolfgang Ho&#x0308;gler offers a practical approach to evaluating a child with recurrent fractures (<b><I>see page <addart type="iti" doi="10.1136/archdischild-2025-328954">86</addart></I></b>). While emphasising the enduring importance of detailed history-taking and careful examination, the authors also integrate advances in imaging and genomic medicine to enhance diagnostic accuracy. Their clear, pragmatic algorithm is especially valuable when navigating complex or atypical presentations.</p> <p>The integration of traditional clinical skills with emerging diagnostic technologies offers a natural transition to a wider theme running through this issue: the growing influence of genomic medicine in paediatric care. Jodie Nguyen and colleagues present a quality improvement project evaluating the implementation of a point-of-care genomic test&mdash;the Genedrive MT-RNR1 assay. The m.1555A&gt;G variant in the mitochondrial...]]></description>
<dc:creator><![CDATA[Gupta, N.]]></dc:creator>
<dc:date>2026-05-18T00:45:55-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2026-330873</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2026-330873</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:title><![CDATA[Epistle]]></dc:title>
<prism:publicationDate>2026-05-15</prism:publicationDate>
<prism:section>Highlights from this issue</prism:section>
<prism:volume>111</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>85</prism:startingPage>
<prism:endingPage>85</prism:endingPage>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/111/3/86?rss=1">
<title><![CDATA[Fifteen-minute consultation: Modern diagnostic approach to the child with recurrent fractures]]></title>
<link>http://ep.bmj.com/cgi/content/short/111/3/86?rss=1</link>
<description><![CDATA[
<p>Children and young people presenting with recurrent fractures pose a diagnostic challenge for clinicians. Such patients require early referral to a tertiary paediatric centre with bone specialists and a multidisciplinary team taking a comprehensive, modern approach to unravel the underlying causes. Using a guiding diagnostic algorithm, incorporating a thorough medical history, informed clinical examinations, targeted laboratory tests, state-of-the-art imaging and molecular genetic analyses, specialists can expedite the identification of underlying causes of bone fragility in children.</p>
<p>The modern diagnostic approach integrates the latest evidence-based guidelines and technological advancements, thus enabling a swift and effective management strategy. This fifteen-minute consultation equips healthcare professionals with the necessary information to optimise history taking and basic case evaluation and provides insights into procedures at tertiary bone centres. Good collaboration among general paediatricians, orthopaedic surgeons and paediatric bone specialists ultimately enhances the care and outcomes for children with recurrent fractures.</p>
]]></description>
<dc:creator><![CDATA[Blaschitz, A., Ho&#x0308;gler, W.]]></dc:creator>
<dc:date>2026-05-18T00:45:55-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-328954</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-328954</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Open access, Best practice and Fifteen Minute Consultations]]></dc:subject>
<dc:title><![CDATA[Fifteen-minute consultation: Modern diagnostic approach to the child with recurrent fractures]]></dc:title>
<prism:publicationDate>2026-05-15</prism:publicationDate>
<prism:section>Best practice</prism:section>
<prism:volume>111</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>86</prism:startingPage>
<prism:endingPage>91</prism:endingPage>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/111/3/92?rss=1">
<title><![CDATA[Fifteen-minute consultation: Acute pancreatitis in paediatrics]]></title>
<link>http://ep.bmj.com/cgi/content/short/111/3/92?rss=1</link>
<description><![CDATA[
<p>Acute pancreatitis is a potentially life-threatening condition that can arise from various aetiologies, including medications, infections, obstructive processes, trauma, systemic diseases or remain idiopathic. Timely and accurate diagnosis, particularly identification of precipitating factors, is essential for effective management. The INSPPIRE (International Study Group of Paediatric Pancreatitis) criteria offer a comprehensive approach to diagnosing and evaluating potential causes. Core management strategies, encompassing fluid resuscitation, pain control, nutritional support and judicious use of antimicrobial agents, are fundamental in minimising unnecessary interventions and optimising patient outcomes, ultimately reducing hospital length of stay. In cases of recurrent acute pancreatitis, further investigation can help identify underlying medical conditions and guide appropriate treatment.</p>
]]></description>
<dc:creator><![CDATA[Talbot, J., Chanchlani, N., Wiskin, A. E., Selvarajan, L.]]></dc:creator>
<dc:date>2026-05-18T00:45:55-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-328996</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-328996</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Best practice and Fifteen Minute Consultations]]></dc:subject>
<dc:title><![CDATA[Fifteen-minute consultation: Acute pancreatitis in paediatrics]]></dc:title>
<prism:publicationDate>2026-05-15</prism:publicationDate>
<prism:section>Best practice</prism:section>
<prism:volume>111</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>92</prism:startingPage>
<prism:endingPage>96</prism:endingPage>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/111/3/97?rss=1">
<title><![CDATA[Joy in work: a multidisciplinary quality improvement project designed to improve staff well-being in an inner-city childrens hospital]]></title>
<link>http://ep.bmj.com/cgi/content/short/111/3/97?rss=1</link>
<description><![CDATA[ <sec id="s1"><st>Summary</st> <p>A staff-led, multidisciplinary quality improvement project addressing workplace well-being in a large inner-city children&rsquo;s hospital.</p> </sec> <sec id="s2"><st>The problem</st> <p>Many health workers report low workplace well-being, which negatively impacts their health and well-being, and patient care. Staff well-being is an important contributor to high-quality patient care.<cross-ref type="bib" refid="R1">1 2</cross-ref><cross-ref type="bib" refid="R2"></cross-ref> Organisations with engaged, happy staff have better patient outcomes, safety, satisfaction, reduced costs, lower sickness rates and higher staff retention.<cross-ref type="bib" refid="R3">3</cross-ref></p> <p>Working with children and families is rewarding but challenging. It offers the chance to make a real difference while working in multidisciplinary teams.<cross-ref type="bib" refid="R4">4 5</cross-ref><cross-ref type="bib" refid="R5"></cross-ref> Health workers in paediatrics face growing pressures, including resource constraints, workforce shortages and increasing patient complexity.<cross-ref type="bib" refid="R6">6</cross-ref> These challenges impact well-being, particularly for frontline staff and those in resource-limited settings, leading to burnout and feelings of being overwhelmed.<cross-ref type="bib" refid="R7">7</cross-ref></p> <p>In the 2023 National Health...]]></description>
<dc:creator><![CDATA[Morrissey, B., Bensted, R., Gopal, G., John, Y., Thaci, E., Bryant, V., Begum, S., Hume, A., Cowen, O., Vaidya, M., Vigille, A., Eleftheriou, G., Evans, K., Minson, S.]]></dc:creator>
<dc:date>2026-05-18T00:45:55-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-328514</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-328514</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:title><![CDATA[Joy in work: a multidisciplinary quality improvement project designed to improve staff well-being in an inner-city childrens hospital]]></dc:title>
<prism:publicationDate>2026-05-15</prism:publicationDate>
<prism:section>Quality improvement short report</prism:section>
<prism:volume>111</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>97</prism:startingPage>
<prism:endingPage>102</prism:endingPage>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/111/3/103?rss=1">
<title><![CDATA[Implementation of a novel point-of-care technology: the Genedrive MT-RNR1 test]]></title>
<link>http://ep.bmj.com/cgi/content/short/111/3/103?rss=1</link>
<description><![CDATA[ <sec id="s1"><st>Summary</st> <p>Quality improvement project implementing the Genedrive MT-RNR1 point-of-care technology into a neonatal intensive care unit (NICU).</p> </sec> <sec id="s2"><st>The problem</st> <p>Gentamicin is a commonly used aminoglycoside antibiotic. The National Institute for Health and Care Excellence (NICE) guidelines recommend gentamicin and benzylpenicillin for first-line treatment of neonatal early-onset sepsis.<cross-ref type="bib" refid="R1">1</cross-ref> However, individuals carrying the m.1555A&gt;G genetic variant on the MT-RNR1 mitochondrial gene are at higher risk of developing irreversible deafness, if given even a single dose of aminoglycoside.<cross-ref type="bib" refid="R2">2 3</cross-ref><cross-ref type="bib" refid="R3"></cross-ref></p> <p>The prevalence of the variant in the general population is 1 in 500.<cross-ref type="bib" refid="R3">3</cross-ref> Despite the risks, gentamicin (with benzylpenicillin) continues to be used due to its effectiveness and narrow spectrum of antibiotic cover, contributing to a lower risk of antibiotic resistance.<cross-ref type="bib" refid="R1">1</cross-ref> It is also recommended that antibiotics should be delivered within 1 hour of identifying or suspecting sepsis.<cross-ref type="bib" refid="R1">1</cross-ref></p> <p>A...]]></description>
<dc:creator><![CDATA[Nguyen, J., Kishore, P., Lawn, C.]]></dc:creator>
<dc:date>2026-05-18T00:45:55-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2024-328158</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2024-328158</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Editor's choice]]></dc:subject>
<dc:title><![CDATA[Implementation of a novel point-of-care technology: the Genedrive MT-RNR1 test]]></dc:title>
<prism:publicationDate>2026-05-15</prism:publicationDate>
<prism:section>Quality improvement short report</prism:section>
<prism:volume>111</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>103</prism:startingPage>
<prism:endingPage>106</prism:endingPage>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/111/3/107?rss=1">
<title><![CDATA[What is radiomics?]]></title>
<link>http://ep.bmj.com/cgi/content/short/111/3/107?rss=1</link>
<description><![CDATA[ <sec id="s1"><st>Introduction</st> <p>Radiomics is an emerging field that combines medical imaging techniques with data science to extract a vast array of quantitative features from images for clinical or research applications. These features, often imperceptible to the human eye, hold the potential to enhance healthcare and improve patient outcomes<cross-ref type="bib" refid="R1">1</cross-ref> through the identification of novel imaging markers that enable precise diagnosis, prognosis and treatment planning for a variety of childhood diseases. Integration of radiomics with other data types, such as genomics,<cross-ref type="bib" refid="R2">2</cross-ref> offers opportunities for further multimodal insights, while longitudinal studies can establish radiomics&rsquo; role in monitoring disease progression or treatment response.</p> <p>Interpretability, accountability and reliability are essential within a healthcare setting. In contrast to &lsquo;black-box&rsquo; artificial intelligence approaches, radiomics typically integrates interpretable algorithms, ensuring that predictions and insights can be understood, validated and trusted by clinicians, offering auditable workflows that are clear and reproducible.</p> <p>While traditional radiological...]]></description>
<dc:creator><![CDATA[Mulvany, T., Griffiths-King, D., Crombie, K., Novak, J., Apps, J. R.]]></dc:creator>
<dc:date>2026-05-18T00:45:55-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2024-328347</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2024-328347</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:title><![CDATA[What is radiomics?]]></dc:title>
<prism:publicationDate>2026-05-15</prism:publicationDate>
<prism:section>Research in practice</prism:section>
<prism:volume>111</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>107</prism:startingPage>
<prism:endingPage>110</prism:endingPage>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/111/3/111?rss=1">
<title><![CDATA[Diagnosis and confirmation of death in children: a focus on the 2025 UK guidelines]]></title>
<link>http://ep.bmj.com/cgi/content/short/111/3/111?rss=1</link>
<description><![CDATA[ <sec id="s1"><st>Background</st> <p>What constitutes death has been discussed and debated throughout history. From a medical perspective, three sets of criteria are now recognised to diagnose death: somatic, circulatory and neurological.</p> <p>The need for neurological criteria has arisen from advances in intensive care and medical technology to support organ function. However, death by neurological criteria, commonly referred to as brain death, presents unique complexities which are further compounded in paediatrics. For example, patients declared dead by neurological criteria may have outward appearances reminiscent of life, there may be different perspectives on which tests reliably indicate brain death across the age spectrum, or there may be family and public uncertainty or wariness about the concept of brain death.</p> <p>Authoritative guidelines help ensure that death is diagnosed in an accurate, standardised and timely manner, which in turn helps maintain public trust in the process of determining death and the medical profession.</p> </sec>...]]></description>
<dc:creator><![CDATA[Jeyaraj, R., Alexander, E. C., Bhayat, S., Brierley, J.]]></dc:creator>
<dc:date>2026-05-18T00:45:55-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2024-328350</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2024-328350</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Guideline review]]></dc:subject>
<dc:title><![CDATA[Diagnosis and confirmation of death in children: a focus on the 2025 UK guidelines]]></dc:title>
<prism:publicationDate>2026-05-15</prism:publicationDate>
<prism:section>Guideline review</prism:section>
<prism:volume>111</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>111</prism:startingPage>
<prism:endingPage>118</prism:endingPage>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/111/3/119?rss=1">
<title><![CDATA[Jaundice in newborn babies under 28 days: NICE guideline 2023 (CG98)]]></title>
<link>http://ep.bmj.com/cgi/content/short/111/3/119?rss=1</link>
<description><![CDATA[ <sec id="s1"><st>Background</st> <p>Jaundice affects 60% of term infants and up to 80% of preterm newborns. Early identification and treatment are necessary to prevent acute bilirubin encephalopathy and kernicterus. In October 2023, the National Institute for Health and Care Excellence (NICE) updated its clinical guideline CG98, &lsquo;Jaundice in newborn babies under 28 days&rsquo; (<cross-ref type="box" refid="B1">box 1</cross-ref>). New recommendations highlighted challenges in identifying jaundice in infants with darker skin and updates regarding investigations for prolonged jaundice.</p> <p><textbox id="B1"><no>Box 1</no><caption><p>Resources</p> </caption> <p><l type="unord"><li><p><A HREF="https://www.nice.org.uk/guidance/cg98">https://www.nice.org.uk/guidance/cg98</inter-ref></p> </li></l></p> <p>Link to the National Institute for Health and Care Excellence (NICE) guideline</p> <p><l type="unord"><li><p><inter-ref locator="https://www.nice.org.uk/guidance/cg98/resources" locator-type="url">https://www.nice.org.uk/guidance/cg98/resources</inter-ref></p> </li></l></p> <p>Link to the NICE treatment threshold graphs</p> <p><l type="unord"><li><p><inter-ref locator="https://www.nice.org.uk/guidance/cg98/evidence" locator-type="url">https://www.nice.org.uk/guidance/cg98/evidence</inter-ref></p> </li></l></p> <p>Link to the NICE guideline committee&rsquo;s evidence review</p> <p><l type="unord"><li><p><inter-ref locator="https://childliverdisease.org/yellow-alert/" locator-type="url">https://childliverdisease.org/yellow-alert/</inter-ref></p> </li></l></p> <p>Link to parent information leaflets about jaundice from the Children&rsquo;s Liver Disease Foundation and their &lsquo;Yellow Alert&rsquo; awareness campaign</p> <p><l type="unord"><li><p><inter-ref locator="https://nhsrho.org/resources/a-parents-guide-to-recognising-jaundice-in-black-and-brown-babies/" locator-type="url">https://nhsrho.org/resources/a-parents-guide-to-recognising-jaundice-in-black-and-brown-babies/</A></p>...]]></description>
<dc:creator><![CDATA[Innerarity, J., Michaud Maturana, M., Mena, J., Pillay, K., Loucaides, E., Mckinnon, K.]]></dc:creator>
<dc:date>2026-05-18T00:45:55-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329317</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329317</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Guideline review]]></dc:subject>
<dc:title><![CDATA[Jaundice in newborn babies under 28 days: NICE guideline 2023 (CG98)]]></dc:title>
<prism:publicationDate>2026-05-15</prism:publicationDate>
<prism:section>Guideline review</prism:section>
<prism:volume>111</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>119</prism:startingPage>
<prism:endingPage>122</prism:endingPage>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/111/3/123?rss=1">
<title><![CDATA[Urinary tract infection (recurrent): antimicrobial prescribing (NICE NG112)]]></title>
<link>http://ep.bmj.com/cgi/content/short/111/3/123?rss=1</link>
<description><![CDATA[ <sec id="s1"><st>Background</st> <p>National Institute for Health and Care Excellence (NICE) guideline NG112<cross-ref type="bib" refid="R1">1</cross-ref> primarily addresses recurrent urinary tract infections (UTIs) in people with a female urinary tract (including women, trans men and non-binary people with a female urinary tract); however, this review explores its relevance to paediatric population.</p> <sec id="s1-1"><st>Information about current guideline</st> <p><l type="unord"><li><p>Title: Urinary tract infection (recurrent): antimicrobial prescribing (NICE NG112) in children, young people and adults who do not have a catheter</p> </li><li> <p>Publication date: October 2018</p> </li><li> <p>Last Updated: December 2024</p> </li><li> <p>Aim: To provide clear, evidence-based guidance on use of antimicrobials in recurrent UTI, focusing on optimising antibiotic use and reducing antibiotic resistance.</p> </li><li> <p>Key stakeholders: NICE, paediatricians, GPs, microbiologists</p> </li></l></p></sec> <sec id="s1-2"><st>Previous Guidelines</st> <p><l type="unord"><li><p>NICE CG54&mdash;UTI in under 16s: diagnosis and management (2007, updated 2018)<cross-ref type="bib" refid="R2">2</cross-ref></p> <p><l type="unord"><li><p>Covers diagnosis, imaging and treatment of first and recurrent UTIs in children.</p> </li><li> <p>Highlights...]]></description>
<dc:creator><![CDATA[Arakkal, S., Lakshman, R.]]></dc:creator>
<dc:date>2026-05-18T00:45:55-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-328991</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-328991</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Guideline review]]></dc:subject>
<dc:title><![CDATA[Urinary tract infection (recurrent): antimicrobial prescribing (NICE NG112)]]></dc:title>
<prism:publicationDate>2026-05-15</prism:publicationDate>
<prism:section>Guideline review</prism:section>
<prism:volume>111</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>123</prism:startingPage>
<prism:endingPage>125</prism:endingPage>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/111/3/126?rss=1">
<title><![CDATA[If it is not a bruise, what else could it be?]]></title>
<link>http://ep.bmj.com/cgi/content/short/111/3/126?rss=1</link>
<description><![CDATA[ <p>You are seeing a 17-month-old boy for a child protection medical examination in community paediatrics.</p> <p>His parents noticed two red marks on his right forearm after returning from nursery. The staff were unable to offer a clear explanation. A safeguarding referral was made due to the marks persisting and remaining unexplained. He is healthy and fully immunised with no personal or family history of bleeding or skin disorders.</p> <p>The patient had appropriate growth, development and a normal systems examination. There was no impaired function, swelling, deformity, erythema or tenderness of the right forearm and wrist.</p> <p>At the examination, the marks were 2 weeks old. There were other non-concerning marks identified as accidental bruises on the exposed limbs.</p> <p>Mark 1 (<cross-ref type="fig" refid="F1">figure 1</cross-ref>) and Mark 2 (<cross-ref type="fig" refid="F2">figure 2</cross-ref>) were flat, non-tender, with irregular borders. They were brown with inner hypopigmentation. Mark 1, located on the lower third of...]]></description>
<dc:creator><![CDATA[Bhatia, S., Asiegbunam, N.]]></dc:creator>
<dc:date>2026-05-18T00:45:55-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329012</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329012</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:title><![CDATA[If it is not a bruise, what else could it be?]]></dc:title>
<prism:publicationDate>2026-05-15</prism:publicationDate>
<prism:section>Epilogue</prism:section>
<prism:volume>111</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>126</prism:startingPage>
<prism:endingPage>127</prism:endingPage>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/111/3/128?rss=1">
<title><![CDATA[Twelve-year-old girl with colour changes to extremities]]></title>
<link>http://ep.bmj.com/cgi/content/short/111/3/128?rss=1</link>
<description><![CDATA[ <p>A 12-year-old girl of Asian genetic ancestry was referred with arthralgia and episodic colour changes affecting her hands and feet. She described her digits turning grey then blue, with painful paraesthesia, particularly in cold environments. She also had a history of intermittent periorbital swelling. On examination, there was pitting of several fingertips and restriction of hips and knees bilaterally. Cardiovascular and respiratory examinations were unremarkable, with no peripheral oedema and normal peripheral pulses.</p> <p>The family provided a photograph taken at home (<cross-ref type="fig" refid="F1">figure 1</cross-ref>).</p> <sec id="s1"><st>Test your knowledge</st> <p><l type="ord"><li><p>What is the likely diagnosis?</p> <p><l type="letterupper"><li><p>Acrocyanosis</p> </li><li> <p>Primary Raynaud&rsquo;s phenomenon</p> </li><li> <p>Secondary Raynaud&rsquo;s phenomenon</p> </li><li> <p>COVID digits</p> </li><li> <p>Erythromelalgia</p> </li></l></p></li><li> <p>What are the most relevant initial tests to identify the diagnosis?</p> <p><l type="letterupper"><li><p>Pulse oximetry</p> </li><li> <p>ANA (Anti-nuclear antibody)</p> </li><li> <p>Nailfold capillaroscopy</p> </li><li> <p>Urinalysis</p> </li><li> <p>None</p> </li></l></p></li><li> <p>Which clinical features are most suggestive of an underlying disease?</p> <p><l type="letterupper"><li><p>Episodes...]]></description>
<dc:creator><![CDATA[Twynam-Perkins, E. J., McLellan, K., Anderson, C., Martin, N.]]></dc:creator>
<dc:date>2026-05-18T00:45:55-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329504</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329504</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:title><![CDATA[Twelve-year-old girl with colour changes to extremities]]></dc:title>
<prism:publicationDate>2026-05-15</prism:publicationDate>
<prism:section>Epilogue</prism:section>
<prism:volume>111</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>128</prism:startingPage>
<prism:endingPage>130</prism:endingPage>
</item>
</rdf:RDF>